SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Morphic Holding, Inc. (MORF) .
Criteria proven by this page:
- VALUE (50/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Analyst consensus target $57.00 (+0% upside) — modest upside expected.
Overall SharesGrow Score: 38/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
50/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — MORF
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio4,636.92
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-3.59
Book Value / Share$0.00
Revenue / Share$0.01
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$57.00 (+0%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2017 |
$-0.74 |
$0.00 |
$-16.92M |
- |
| 2018 |
$-1.04 |
$3.36M |
$-23.83M |
-709.7% |
| 2019 |
$-1.44 |
$16.98M |
$-43.33M |
-255.2% |
| 2020 |
$-1.47 |
$44.95M |
$-45M |
-100.1% |
| 2021 |
$-2.63 |
$19.79M |
$-94.24M |
-476.1% |
| 2022 |
$-1.55 |
$70.81M |
$-59.04M |
-83.4% |
| 2023 |
$-3.59 |
$521K |
$-152.1M |
-29192.9% |
